Zhang Shuxia, Zhu Ting, Li Qiaoyu, Sun Guibo, Sun Xiaobo
Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Front Pharmacol. 2021 Nov 17;12:765075. doi: 10.3389/fphar.2021.765075. eCollection 2021.
Ischemic stroke (IS) is a disease that is characterized by high mortality and disability. Recent studies have shown that LncRNA-mediated competing endogenous RNA (ceRNA) networks play roles in the occurrence and development of cerebral I/R injury by regulating different signaling pathways. However, no systematic analysis of ceRNA mechanisms in IS has been reported. In this review, we discuss molecular mechanisms of LncRNA-mediated ceRNA networks under I/R injury. The expression levels of LncRNAs, microRNAs (miRNAs), and messenger RNAs (mRNAs) and their effects in four major cell types of the neurovascular unit (NVU) are also involved. We further summarize studies of LncRNAs as biomarkers and therapeutic targets. Finally, we analyze the advantages and limitations of using LncRNAs as therapeutics for IS.
缺血性中风(IS)是一种具有高死亡率和高致残率的疾病。最近的研究表明,长链非编码RNA(LncRNA)介导的竞争性内源RNA(ceRNA)网络通过调节不同的信号通路在脑缺血/再灌注(I/R)损伤的发生和发展中发挥作用。然而,尚未有关于IS中ceRNA机制的系统分析报道。在本综述中,我们讨论了I/R损伤下LncRNA介导的ceRNA网络的分子机制。还涉及了LncRNA、微小RNA(miRNA)和信使RNA(mRNA)的表达水平及其在神经血管单元(NVU)四种主要细胞类型中的作用。我们进一步总结了将LncRNA作为生物标志物和治疗靶点的研究。最后,我们分析了将LncRNA用作IS治疗方法的优势和局限性。